Cocco, Giuseppe, M.D. Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2008
NCT01796093
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2008

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 4 Trials (2)

digoxin (lanoxin) (2 trials)

ivabradine (corlanor) (2 trials)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Heart Failure (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 2
  • # of Trial APIs: 2